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Objectives The goal of this study was to determine the diagnostic accuracy of dynamic 3-dimensional (3D) whole heart
myocardial perfusion cardiovascular magnetic resonance (CMR) against invasively determined fractional flow
reserve (FFR) and to establish the correlation between myocardium at risk defined by using the invasive Duke
Jeopardy Score (DJS) and noninvasive 3D whole heart myocardial perfusion CMR.
Background 3D whole heart myocardial perfusion CMR overcomes the limited spatial coverage of conventional two-
dimensional perfusion CMR methods and allows estimation of the extent of ischemia. The method has shown
good diagnostic accuracy for the detection of coronary artery disease (CAD) as defined by using quantitative cor-
onary angiography. However, quantitative coronary angiography does not provide a functional assessment of
CAD as available from pressure wire–derived FFR. In the catheter laboratory, the DJS can complement FFR to
estimate the myocardium at risk.
Methods Fifty-three patients referred for angiography underwent rest and adenosine stress 3D whole heart myocardial
perfusion CMR at 3-T. Perfusion was scored visually on a patient and coronary territory basis, and ischemic bur-
den was calculated by quantitative segmentation of the volume of hypoenhancement. FFR was measured in ves-
sels with 50% severity stenosis and an FFR 0.75 considered as hemodynamically significant. The DJS was
calculated from the coronary angiograms to quantify the myocardium at risk.
Results FFR was measured in 64 of 159 coronary vessels, and 39 had an FFR 0.75. Sensitivity, specificity, and diag-
nostic accuracy of CMR for the detection of significant CAD were 91%, 90%, and 91%, on a patient basis and
79%, 92%, and 88%, respectively, by coronary territory. There was a strong correlation between the DJS and
ischemic burden on CMR (p  0.0001; Pearson’s r  0.82).
Conclusions 3D whole heart myocardial perfusion CMR accurately detects functionally significant CAD as defined by using
FFR and provides an assessment of ischemic burden in agreement with the invasive DJS. The accurate detection
of significant CAD combined with an estimation of ischemic burden by using 3D myocardial perfusion CMR holds
promise for noninvasive guidance of therapy and risk stratification of patients with CAD. (J Am Coll Cardiol
2012;60:756–65) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.02.075Cardiovascular magnetic resonance (CMR) is a rapidly
evolving method for myocardial perfusion imaging (1,2).
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than single-photon emission computed tomography (3).
A limitation of myocardial perfusion CMR has been that
the conventionally used two-dimensional (2D) acquisition
methods cover the heart with a limited number (typically 3)
of noncontiguous imaging slices.
See page 766
This selective coverage potentially limits diagnostic yield
and impacts on the reliable quantitation of ischemic
burden. More recently, three-dimensional (3D) myocar-
dial perfusion CMR methods have been proposed to
overcome the limitation of spatial coverage (4). 3D
methods have shown good diagnostic accuracy for the
detection of coronary artery disease (CAD) as determined
by using quantitative coronary angiography (QCA) (5).
Since the original reports on 3D myocardial perfusion
CMR, technological advances have led to improved
signal homogeneity, in particular at 3-T, and better
reconstruction accuracy of temporally resolved signal
intensity curves (6,7). These second-generation 3D
methods have not been tested in a clinical setting.
Furthermore, comparisons of myocardial perfusion imag-
ing with QCA are inherently limited because of the
variable relationship between the severity of coronary
stenosis and its functional significance (8). A more
appropriate validation of perfusion imaging can be made
against invasive pressure wire– derived fractional flow
reserve (FFR) measured during coronary angiography.
FFR 0.75 correlates closely with objective evidence of
reversible ischemia, and FFR-guided percutaneous coro-
nary intervention confers a prognostic benefit (9).
Although one of the key advantages of FFR is that
it is largely independent of vessel size and other con-
founders, this also implies that FFR provides no infor-
mation on the extent of myocardium at risk, a separate
marker of prognosis. For invasive estimation of ischemic
burden, the Duke Jeopardy Score (DJS), which correlates
the myocardium at risk with prognosis, has been
described (10).
The objective of this study was to determine the diag-
nostic accuracy of a 3D whole heart myocardial perfusion
CMR against FFR to detect flow-limiting coronary artery
stenosis. A secondary aim was to establish the correlation
between myocardium at risk defined by the DJS derived
from angiographic data and ischemic burden as defined by
the volume of hypoperfused myocardium on 3D whole heart
myocardial perfusion CMR.
Methods
Patient population. The study was approved by the local
research ethics committee, and all subjects gave written
informed consent to participate. Fifty-five consecutive pa-
tients with known or suspected CAD were recruited beforeclinically indicated invasive coronary
angiography studies. Exclusion cri-
teria were recent (3 months) acute
coronary syndromes, coronary artery
bypass grafting, and contraindica-
tions to CMR imaging (including
pacemakers and claustrophobia) or
adenosine stress testing (poorly
controlled obstructive airway dis-
ease and second- or third-degree
atrioventricular block).
On the angiography procedure
day, a full medical history was
taken and a physical examination
performed. Symptoms of chest
pain were recorded in accordance
with the Canadian Cardiovascu-
lar Society angina grading scale.
A baseline electrocardiogram was
performed and analyzed for the
presence of Q waves or bundle branch block using defined
Minnesota criteria (11).
CMR protocol. All subjects were scanned in the supine
position on a 3-T magnetic resonance scanner (Achieva,
Philips Healthcare, Best, the Netherlands) equipped with
dual-source parallel RF transmission (MultiTransmit) tech-
nology (7) and a 6-channel cardiac phased-array receiver
coil. Patients were monitored throughout the scan with a
4-lead vectorcardiogram, respiratory belt, and blood pres-
sure monitoring. For perfusion imaging, a 3D spoiled turbo
gradient-echo sequence was used (TR/TE/flip angle 1.8
ms/0.7 ms/15°; saturation prepulse delay 150 ms; acquisi-
tion timed to end-systole; partial Fourier acquisition; 10
fold k-t acquisition with 11 training profiles leading to a net
acceleration of 7.0; k-t principal component analysis recon-
struction [6]; reconstruction of 12 contiguous slices of
5-mm thickness; typical field of view 350  350 mm2; and
acquired voxel size 2.3  2.3  5mm3).
Stress perfusion images were acquired during intravenous
adenosine-induced hyperemia administered for 4 min at 140
g/kg/min. An intravenous bolus of 0.075 mmol/kg of
gadobutrol (Gadovist, Bayer Schering Pharma, Berlin, Ger-
many) was administered at a rate of 4.0 ml/s followed by a
20-ml saline flush (Medrad Spectris Solaris power injector,
Pittsburgh, Pennsylvania).
Stress perfusion CMR was followed by cine imaging
covering the left ventricle in 10 to 12 short-axis sections and
a rest perfusion scan performed 15 min later using the same
concentration and volume of contrast agent (0.075 mmol/kg) as
for stress perfusion. Late gadolinium enhancement (LGE)
images (0.15 mmol/kg cumulative dose) were acquired in
the same short-axis geometry after an additional 15 min
using a conventional method (12).
Catheter laboratory protocol. FFR was calculated as:
(Pd – Pv)/(Pa – Pv), during hyperemia induced by infusion
Abbreviations
and Acronyms
2D  two-dimensional
3D  three-dimensional
CAD  coronary artery
disease
CI  confidence interval
CMR  cardiovascular
magnetic resonance
DJS  Duke Jeopardy Score
FFR  fractional flow
reserve
LGE  late gadolinium
enhancement
QCA  quantitative
coronary angiography
ROC  receiver-operating
characteristicof intravenous adenosine at 140 g/kg/min, where Pd,
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atrial pressures, respectively (13). FFR was performed in
all coronary arteries with luminal stenosis 50% in 2
orthogonal views. FFR 0.75 was considered to repre-
sent hemodynamically significant coronary stenosis. Ves-
sels with chronic total occlusions were considered as
significantly stenosed, and FFR measurements were not
attempted. Angiographic images were analyzed quantita-
tively by using QCA (Medcon Ltd., Tel Aviv, Israel) by
a blinded observer. Significant CAD was defined as
70% diameter stenosis of the left anterior descending,
circumflex, or right coronary arteries with 2 mm
luminal diameter or 50% diameter stenosis for the left
main stem.
Duke Jeopardy Score. The DJS was calculated by using
methods as originally described from myocardium at risk
depending on the size and location (10). The coronary tree
was divided into 6 segments of nearly equal myocardial
perfusion (e.g., left anterior descending artery, major septal
perforator, major diagonal branch, circumflex artery, major
obtuse marginal branch artery, posterior descending artery).
A score of 2 for each significant lesion was given; thus, a
total maximal score of 12 could be derived. The cardiolo-
gists performing the coronary angiogram and all
angiography-derived measurements were blinded to the
CMR scan result.
CMR analysis. Two experienced observers, who were
blinded to clinical details, visually analyzed the CMR
images by using standard software (ViewForum, Philips
Healthcare). Stress and rest perfusion scans and LGE
images were viewed simultaneously. Image quality was
graded on a scale from 1 to 4 (1  uninterpretable, 2 
poor, 3  good, and 4  excellent). Image artifacts were
recorded and categorized as breathing related, subendocar-
dial rim artifacts, or related to the reconstruction of under-
sampled data. A perfusion defect was considered present if
reduced contrast uptake was seen at stress with 25%
transmurality in 1 contiguous slice persisting for 4
consecutive dynamic time points but not present at rest.
Ischemia was only reported if the perfusion defect extended
outside of any scar noted on matching LGE images.
Perfusion defects were scored on a scale from 0 to 3 (0 
normal [all segments normal, no artifacts], 1  probably
normal [1 segment affected or suspected artifacts], 2 
probably abnormal [2 segments affected or artifacts], 3 
definitely abnormal [2 segments affected and no artifacts])
for each perfusion territory to provide a summed stress score
by each of the 2 observers. In case of disagreement,
arbitration from a third observer was sought. For patient
analysis, all normal and probably normal scores were clas-
sified as being normal and probably abnormal, and definitely
abnormal scores were grouped as abnormal.
Perfusion defects were assigned to coronary territories by
using the American Heart Association coronary arterial
segment model (14). To simulate a comparison of 3D whole
heart with 2D multislice myocardial perfusion CMR, onlyslices 3, 7, and 11, representing apical, mid-myocardial, and
basal sections, were reviewed in a separate analysis session,
and reported a per-patient and per-vessel basis.
Ischemic volume calculation. The ischemic volume of
myocardium was calculated by a separate blinded observer
using GTVolume software (GyroTools Version 1.4, Zurich,
Switzerland). A previously described method, which defines
ischemic volume as tissue at an intensity threshold of 2
SDs below the signal of remote myocardium in the stress
perfusion dynamic with the clearest delineation of a perfu-
sion defect, was used (5). The total ischemic volume was
calculated by summation of the hypoperfused areas in each
slice. In patients with scar on LGE, scar volume was
calculated in a similar fashion and peri-infarct ischemia was
derived as the difference between the ischemia and scar
volumes. The analysis was initially performed for all cases
and then repeated for correctly identified cases only (i.e.,
excluding studies with false-positive and false-negative
results).
To test reproducibility of detecting ischemic volumes,
interobserver variability was assessed in a subset of 10
patients by a second reader fully blinded to clinical details
and previous results. For intraobserver variability, the first
reader repeated measurements of ischemic volumes 2 weeks
later.
Statistical analysis. Data analysis was performed by using
SPSS version 19.0 (SPSS Inc., Chicago, Illinois). Analysis
was performed on both a patient and coronary territory basis
to determine sensitivity, specificity, and negative and posi-
tive predictive values. These values were calculated for
CMR to detect FFR 0.75. Receiver-operating character-
istic (ROC) curve analysis was performed using the summed
perfusion scores of the visual analysis. The interobserver
variability of perfusion analysis was calculated using the
kappa coefficient.
Interobserver and intraobserver variability of ischemic
burden data, as determined with CMR, was calculated by
using Bland-Altman analysis. Correlation between interob-
server and intraobserver variability and the DJS and CMR
ischemic burden was determined by using Pearson’s test of
correlation with a 2-tailed test of significance. For all
analyses, p  0.05 was considered significant.
Results
Patient population. Of the 55 patients recruited to the
study, 1 study was incomplete because of claustrophobia and
1 was excluded because the CMR image quality was deemed
uninterpretable. A total of 53 patients (41 men; mean age
63 years) thus formed the final population for analysis
(Table 1).
Coronary angiography. Angiography was performed, on
average, 2 days (range 0 to 14 days) after the CMR scan
(Table 2). The overall disease prevalence in the study
population was 64%. Of the 159 vessels analyzed, 72 (45%)
vessels contained 50% diameter stenosis on visual assess-
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had heavily calcified long complex lesions, and in 6 vessels,
which were either completely or subtotally occluded. These
arteries were deemed significantly stenosed for the purpose
of the analysis. FFR was performed in the remaining 64
arteries. Of these, 39 had an FFR0.75 and 25 had an FFR
0.75. The total number of vessels with significant stenosis
was thus 47. Twenty-four patients had single-vessel disease,
7 patients had 2-vessel disease, and 3 patients had 3-vessel
disease as defined by a FFR 0.75.
QCA was retrospectively performed in all vessels and did
ot reveal any vessel with 50% stenosis that was not
assessed by FFR. In the vessels with FFR 0.75, mean
iameter stenosis was 48.7%; in vessels with FFR 0.75,
iameter stenosis was 75.6%.
The mean FFR in vessels reported negative for ischemia
y perfusion imaging was 0.82, (range 0.68 to 0.95; median
.83) and the diameter stenosis in these vessels was 56.6%.
he mean FFR in vessels reported as positive for ischemia
y perfusion imaging was 0.61 (range 0.30 to 0.86; median
Patient Demographic Characteristics (N  53)Table 1 Patient Demographic Characteristics (N  53)
Male 41 (77.4)
Age (yrs) 63.5 10.8
Range 43–83
BMI, kg/m2 27.5 4.1
Previous coronary intervention 14 (26.4)
Normal LV function 49 (92.5)
Canadian Cardiovascular Society
Angina Grading Scale
No pain or atypical symptoms 16 (30.2)
Class 1 24 (45.3)
Class 2 10 (18.9)
Class 3 3 (5.7)
Class 4 0 (0)
Baseline electrocardiogram
Q-wave 4 (7.5)
Left bundle branch block 3 (5.7)
Right bundle branch block 1 (1.9)
Cardiovascular risk factors
Diabetes 16 (30.2)
Dyslipidemia 44 (83.0)
Current smoker 9 (17.0)
Hypertension 35 (66.0)
Family history 20 (37.7)
Peripheral vascular disease 3 (5.7)
Medications
Aspirin 51 (96.2)
Clopidogrel 19 (35.8)
Beta-blocker 35 (66.0)
Statin 50 (94.3)
Angiotensin-converting enzyme inhibitor or
angiotensin receptor blocker
32 (60.4)
Nitrate 12 (22.6)
Values are n (%) or mean  SD.
BMI  body mass index; LV  left ventricle..66) with a mean diameter stenosis of 71.7% (Fig. 1).tatistical significance was observed between the FFR of the
groups (p  0.0001) and for QCA (p  0.0013).
MR imaging. Average examination time per patient was
1 4 min. Typical symptoms were experienced in 46 of 53
atients during adenosine stress with mean blood pressure
hanging from 131/71 to 124/70 mm Hg (systolic p 
.001; diastolic p 0.16) and heart rates increasing from 68
o 81 beats/min (p 0.01). Subendocardial LGE was found
X-ray Angiography DataTable 2 X-ray Angiography Data
Time from CMR scan (days) 3.2 3.3 (range 0–14;
mode 0; median 2.0)
Resting systolic blood pressure (mm Hg) 128.7 20.4
Resting diastolic blood pressure (mm Hg) 74.0 12.9
Resting heart rate (beats/min) 66.5 13.4
FFR systolic blood pressure (mm Hg) 121.3 19.3
FFR diastolic blood pressure (mm Hg) 72.6 11.4
FFR heart rate (beats/min) 81.0 15.8
Vessels FFR measured (per patient) 1.2 0.7
Vessels with FFR 0.75 25
Vessels with FFR 0.75 39
LAD 18
Cx 9
RCA 12
Patients with FFR positive
1-vessel disease 24 (45.3)
2-vessel disease 7 (13.2)
3-vessel disease 3 (5.7)
QCA in vessels with FFR 0.75 (% diameter stenosis) 48.7 21.8
QCA in vessels with FFR 0.75 (% diameter stenosis) 75.6 12.3
Values are mean  SD, n, or n (%).
CMR  cardiovascular magnetic resonance; Cx  circumflex coronary artery; FFR  fractional
ow reserve; LAD  left anterior descending coronary artery; RCA  right coronary artery; QCA 
uantitative coronary angiography. *Includes 2 vessels with heavily calcified lesions and 6 vessels
ith chronic occlusion, in which FFR was not performed. These 8 vessels were deemed significantly
tenosed.
Figure 1 Box Plot Comparing FFR With
3D Whole Heart Myocardial Perfusion CMR
Relationship between three-dimensional (3D) whole heart myocardial perfusion
cardiovascular magnetic resonance (CMR) versus fractional flow reserve (FFR)
(64 coronary arteries). The mean FFR in the cohort is marked with a dotted
black line: the mean FFR in coronary arteries with normal perfusion CMR was
0.82 versus a mean FFR of 0.61 in coronary arteries with abnormal perfusion
CMR.
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1 patient. There was no significant difference in rest or stress
hemodynamic data between 3D whole heart myocardial
perfusion CMR and angiography (all p values 0.05)
(Tables 2 and 3).
Image quality. The median image quality score was good
(3.1  0.5). The main artifacts seen were subendocardial
dark rim–related artifacts in 7 patients (13%) and breathing
artifact in 8 patients (15%), although the overall quality was
deemed sufficient to make a diagnosis in all of these cases.
Agreement between observers for the identification of
abnormal perfusion per coronary territory showed a kappa of
0.94, indicating excellent agreement. In 4 patients (2.5% of
coronary territories), a third reader was involved to arbitrate
the remaining cases.
CMR analysis versus FFR. When analyzed per patient
(Table 4), visual analysis of 3D whole heart myocardial
perfusion CMR images yielded a sensitivity of 91.2% (95%
confidence interval [CI]: 75.2 to 97.7), specificity of 89.5%
(95% CI: 65.5 to 98.2), and diagnostic accuracy of 90.6% for
Sensitivity and Specificity of 3D Whole HeartMyocardial Perfusion CMR Versus C ronaryAngiography and FFR on Patient Basis
Table 4
Sensitivity and Specificity of 3D Whole Heart
Myocardial Perfusion CMR Versus Coronary
Angiography and FFR on Patient Basis
CMR 3D
Perfusion
Coronary Angiography/FFR
TotalCAD Negative CAD Positive
Test positive 2 31 33
Test negative 17 3 20
Totals 19 34 53
Value
95% Confidence Interval
Lower Limit Upper Limit
Prevalence 0.642 0.497 0.765
Sensitivity 0.912 0.752 0.977
Specificity 0.895 0.655 0.982
CMR DataTable 3 CMR Data
Scanning time (min) 50.8 4.2 (range 42–66)
Resting systolic blood pressure (mm Hg) 131.1 23.5
Resting diastolic blood pressure (mm Hg) 70.812.7
Resting heart rate (beats/min) 67.9 16.7
Stress systolic blood pressure (mm Hg) 124.5 22.2
Stress diastolic blood pressure (mm Hg) 70.1 11.4
Stress heart rate (beats/min) 81.1 18.3
Image quality 3.1 0.5
Artifact
Breathing 8 (15.1)
Subendocardial rim 7 (13.2)
Adenosine symptoms 46 (86.8)
Adenosine complications 0
Late gadolinium enhancement
Full-thickness 1 (1.9)
Partial-thickness 4 (7.5)
Values are mean  SD or n (%).
CMR  cardiac magnetic resonance.CAD  coronary artery disease; 3D  three-dimensional; other abbreviations as in Table 2.the detection of significant coronary artery stenosis defined
by a FFR 0.75. The positive predicative value was 93.9%
(95% CI: 78.4 to 98.9) and the negative predictive value was
85.0% (95% CI: 61.1 to 96.0). ROC analysis showed an area
under the curve of 0.89 (95% CI: 0.785 to 0.991; p 
0.0001). See Figure 2A for the ROC curve. Case examples
are shown in Figures 3A and 3B.
When analyzed per vessel territory (Table 5), sensitivity
was 78.7% (95% CI: 63.9 to 88.8), specificity was 92.0%
(95% CI: 84.9 to 96.0), and diagnostic accuracy was 88.1%.
The positive predictive value was 80.4% (95% CI: 65.6 to
90.1), and the negative predictive value was 91.2% (95% CI:
Figure 2
Receiver-Operating Characteristics
Curves for 3D Whole Heart Myocardial Perfusion
CMR Versus FFR for Patients and Coronary Territories
(A) Analysis per patient. Receiver-operating characteristic (ROC) curve showing
sensitivity and specificity of the summed stress score of 3D whole heart myo-
cardial perfusion CMR visual analysis to detect a hemodynamically significant
coronary stenosis using a dichotomous value of 0.75 for FFR. The area under
the curve was 0.89. (B) Analysis per coronary territory. ROC curve showing
sensitivity and specificity of the summed stress score of 3D whole heart myo-
cardial perfusion CMR visual to detect a hemodynamically significant coronary
stenosis using a dichotomous value of 0.75 for FFR. The area under the curve
was 0.88. Abbreviations as in Figure 1.
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of 0.88 (95% CI: 0.801 to 0.994; p  0.0001). Please see
Figure 2B for the ROC curve.
When using only 3 slices of the whole heart perfusion
datasets for analysis, the sensitivity, specificity, and diagnos-
tic accuracy were 85.3% (95% CI: 68.2 to 94.4), 84.2% (95%
CI: 59.5 to 95.8) and 84.9% on a patient basis. ROC
analysis showed an area under the curve of 0.845. For the
vessel analysis, sensitivity, specificity and diagnostic accuracy
were 74.4% (95% CI: 59.4 to 85.6), 88.4% (95% CI: 80.6 to
93.4), and 84.3% with an area under the ROC curve of 0.81.
None of these values were significantly different from the
whole heart analysis.
CMR analysis versus QCA. Visual analysis of 3D whole
heart myocardial perfusion CMR images, on a patient basis,
yielded a sensitivity, specificity, and diagnostic accuracy of
87.9% (95% CI: 70.9 to 96.0), 80.0% (95% CI: 55.7 to
93.4), and 84.9%, respectively, for the detection of signifi-
cant CAD defined by using QCA. These data are summa-
rized in Table 6.
Ischemic burden versus DJS. The mean percentage isch-
emic volume (Table 7) on perfusion CMR was 9.9 
10.9%. The mean DJS was 4.0 3.9. The mean percentage
of ischemia volume for DJS of 0, 6, and 12 were 0%, 13.1%,
and 36.7%, respectively. Figure 4 shows an example of the
Figure 3 Case Examples: 3D Whole Heart Myocardial Perfusion
During Adenosine Stress Versus X-Ray Coronary Angio
(A) A subendocardial defect is seen in the anterior and anteroseptal segments ex
left anterior descending coronary lesion with an FFR of 0.61. (B) A transmural def
the apex. Invasive x-ray angiography demonstrated an ostial circumflex coronary le
pressure; Pd  distal coronary pressure.calculation of ischemia calculation.Pearson’s correlation coefficient showed a strong correla-
tion (r  0.82; 95% CI: 0.70 to 0.89) between the DJS and
ischemic volume on CMR (p  0.0001). If only patients
orrectly identified by using perfusion CMR (48 of 53) were
ncluded in the analysis, the correlation was stronger (r 
.87; 95% CI: 0.78 to 0.93; p 0.0001) (Fig. 5). Mean bias
on Bland-Altman analysis was 0.1 ml (95% CI: –3.1 to 3.3)
for intraobserver variability and 0.05 ml (95% CI: –1.8 to
1.9) for intraobserver variability. Pearson’s correlation was
very strong for both interobserver (r  0.96) and intraob-
server (r  0.98) variability (Figs. 6A and 6B).
Discussion
This study found that 3D whole heart myocardial perfusion
CMR accurately predicts the presence of hemodynamically
significant coronary artery stenosis as measured by using
FFR. In addition, it demonstrated close agreement between
estimates of ischemic volume from 3D whole heart myo-
cardial perfusion CMR and an invasive index of ischemic
burden.
3D acquisition methods overcome some of the remaining
limitations of myocardial perfusion CMR; specifically, the
limited myocardial coverage offered by conventionally used 2D
methods. Furthermore, 3D acquisition is more signal-to-noise
R
hy and FFR
g from the base to the apex. Invasive x-ray angiography demonstrated a proximal
seen from the lateral to inferolateral segments extending from the base toward
ith an FFR of 0.31. FFR  fractional flow reserve; HR  heart rate; Pa  aorticCM
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cardiac phase. 3D myocardial perfusion CMR has become
feasible as a result of recent advances in data acquisition speed,
with several different methods proposed (4,15,16).
Following initial feasibility studies, a recent larger clinical
study reported a sensitivity of 91.7% and a specificity of
74.3% of 3D myocardial perfusion CMR for the detection
of coronary stenosis on QCA on a patient basis (5).
However, QCA correlates poorly with the hemodynamic
effect of a coronary stenosis because of effects of lesion
proximity and length, calcification, collateral vessels, and dy-
namic changes in vasomotor tone (8). Pressure wire–derived
FFR, which was the endpoint in the current study, is consid-
ered the reference standard for assessing the hemodynamic
significance of atherosclerotic coronary lesions and is a more
appropriate comparator for ischemia imaging than QCA.
Determining the functional significance of coronary ste-
nosis is directly related to patient outcome, as shown for
invasive assessment in the FAME and DEFER (9,17)
cohorts and for noninvasive imaging in COURAGE and
other studies (18–20). Furthermore, a substudy of FAME
suggested visual and functional disparity, which highlights
the need for functional assessment in patients with CAD
(21). For these reasons, current guidelines recommend the use
Sensitivity and Specificity of 3D Whole HeartMyocardial Perfusion CMR Versus C ronaryAngiography and FFR on C ronary Territory Basis
Table 5
Sensitivity and Specificity of 3D Whole Heart
Myocardial Perfusion CMR Versus Coronary
Angiography and FFR on Coronary Territory Basis
CMR 3D Perfusion
Coronary Angiography/FFR
TotalsAbsent Present
Test positive 9 37 46
Test negative 103 10 113
Totals 112 47 159
Value
95% Confidence Interval
Lower Limit Upper Limit
Prevalence 0.296 0.227 0.374
Sensitivity 0.787 0.639 0.888
Specificity 0.920 0.849 0.960
Abbreviations as in Tables 2 and 4.
Sensitivity and Specificity of 3D Whole HeartMyocardial Perfusion CMR Versus C ronaryAngiography and QCA on a Patient Basis
Table 6
Sensitivity and Specificity of 3D Whole Heart
Myocardial Perfusion CMR Versus Coronary
Angiography and QCA on a Patient Basis
CMR 3D Perfusion
Coronary Angiography/QCA
TotalCAD Negative CAD Positive
Test positive 4 29 33
Test negative 16 4 20
Totals 20 33 53
Value
95% Confidence Interval
Lower Limit Upper Limit
Prevalence 0.642 0.497 0.765
Sensitivity 0.879 0.709 0.960
Specificity 0.800 0.557 0.934QCA  quantitative coronary angiography; other abbreviations as in Tables 2 and 4.of functional testing before elective revascularization (22). In
linical routine, however, fewer than one-half of patients are
valuated noninvasively before revascularization (23).
This study demonstrates excellent agreement between
FFR and 3D whole heart myocardial perfusion CMR.
Compared with the previous study, which compared 3D
myocardial perfusion CMR with QCA, the specificity in
the current analysis was higher (89.5% vs. 74.3%) whereas
sensitivity was the same at 91% (5). The increased specificity
of our analysis, reflecting a lower false-positive rate, is likely
to relate to vessels that cause no functional flow limitation
despite appearing significant on QCA. We observed a
similar difference in specificity between the FFR and QCA
analysis in the current study (89.5% vs. 80.0%).
In the current study, whole heart analysis did not statis-
tically outperform the analysis of only 3 equally distributed
slices of the 3D dataset, intended to simulate conventional
2D myocardial perfusion CMR methods. However, select-
ing 3 slices of a 3D dataset for analysis is not equivalent to
the acquisition of a 3-slice 2D dataset. In a 3D dataset, all
images are acquired in 1 optimized cardiac phase (systole in
our study), which cannot be achieved in a multislice 2D
acquisition. Conversely, 2D acquisition would yield a higher
in-plane spatial resolution in a shorter acquisition time than
3D acquisition if a similar undersampling factor was ap-
plied. Further technical differences exist between 2D and
3D acquisitions that affect signal and contrast behavior of
the acquired images. Our results can therefore only give an
indication of the relative performance of 2D versus 3D
myocardial perfusion CMR, and only an adequately pow-
ered head-to-head comparison of the 2 acquisition methods
can provide conclusive evidence of their relative diagnostic
performance. However, as demonstrated in this study, 3D
acquisition has other advantages, in particular a more
reliable estimation of ischemic volume.
We observed a strong correlation between ischemic
burden on 3D whole heart myocardial perfusion CMR and
the invasive DJS. Proximal lesions with a higher invasive
score showed a higher volume of ischemia on CMR.
Although not frequently used, invasive scores of ischemic
burden have clinical legitimacy because the magnitude of
myocardium at risk due to severe coronary stenosis is
Ischemia Volumes According to 3D Whole HeartMyocardial Perfu ion CMR and Duke JeopardyScor s (n  53)
Table 7
Ischemia Volumes According to 3D Whole Heart
Myocardial Perfusion CMR and Duke Jeopardy
Scores (n  53)
Score
LV
Volume, ml
Ischemic
Volume, ml
Myocardial
Ischemia, %
DJS
Score
Minimum 50.2 0.0 0.0 0
Median 68.0 8.1 11.5 4
Maximum 106.4 33.1 38.0 12
Mean 70.1 7.9 9.9 4.0
SD 12.3 8.0 10.9 3.9
DJS  Duke Jeopardy Score; LV  left ventricular.associated with an adverse prognosis (10,24,25), and isch-
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assessment of stenosis severity, location, and 5-year survival
of patients with scores of 2, 6, and 12 of 97%, 85%, and
6%, respectively (10). Noninvasive assessment of myocar-
ium at risk has similar prognostic relevance and an isch-
mic burden 10% to 12% may serve as a threshold at
hich revascularization conveys prognostic benefit over
edical therapy alone (26).
Our study thus shows that 3D whole heart myocardial
erfusion CMR allows both the detection of ischemia and
rovides an estimate of the extent of myocardium at risk.
uch a noninvasive assessment may convey clinical advan-
ages over invasive assessment. Compared with FFR-guided
evascularization, noninvasive imaging is more suited for
erial assessment and avoids potential iatrogenic complica-
ions, which could have economic implications, particularly
n the multivessel setting (27). Although not formally
Figure 4 Case Example: 3D Whole Heart Myocardial Perfusion
Versus Duke Jeopardy Score
A defect is seen in the inferior, inferoseptal, and inferolateral segments of 50%
ing a proximal right coronary lesion with a fractional flow reserve of 0.67. The circ
calculated as 12.3% of the myocardium (red). The area at risk calculated by usingssessed in the current study given the low prevalence ofprior myocardial infarction, the combination of 3D myo-
cardial perfusion with LGE CMR will also permit a parallel
assessment of ischemia and infarction in equivalent imaging
planes, which is not possible with invasive assessment. A
comprehensive assessment with 3D CMR methods thus
holds promise as a noninvasive diagnostic and risk assess-
ment tool for patients with known or suspected CAD.
Study limitations. This study investigated a population
with a high disease prevalence. Future studies will be
required to establish the diagnostic performance of 3D
myocardial perfusion CMR in lower-risk patient groups. To
minimize patient complications and to be consistent with
clinical practice, FFR was only measured in vessels with
50% coronary stenosis. It cannot be excluded that some
lesions of50% luminal stenosis may have had an abnormal
FFR. We chose an FFR value of 0.75 as significant but
recognize that the functional significance of “gray zone”
During Adenosine Stress With Calculation of Ischemia Burden
urality extending from the base to apex. Invasive x-ray angiography demonstrat-
had a mid-course lesion with a negative FFR of 0.82. The ischemic volume was
uke Jeopardy Score was 4. Abbreviations as in Figure 1.CMR
transm
umflex
the DFFR values (0.75 to 0.80) remains uncertain.
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Whole Heart Perfusion CMR Versus FFR August 21, 2012:756–65As in all studies comparing angiographic and imaging
methods, we may not have correctly assigned all myocardial
segments to the appropriate coronary artery. This limitation
is likely to have accounted for some of the reduced sensi-
tivity of per-vessel territory compared with per-patient
analysis.
Both CMR and the DJS have limitations for the calcu-
lation of the ischemic burden. 3D whole heart myocardial
erfusion CMR is a novel method, and no formal
alidation of estimates of ischemia volume with this method
gainst a recognized reference test such as myocardial
erfusion scintigraphy has been performed to date. The
ethod of estimating ischemic volume from a single
rame of the dynamic CMR data that was used in the
urrent study and the previous report by Manka et al. (5)
requires further validation. It should be noted that this
method is not a substitute for quantitative estimation of
myocardial blood flow, which has been used in other
studies. Our analysis method provides a relatively fast but
visual measurement of ischemic burden, whereas quanti-
tative analysis methods of myocardial blood flow are more
time-consuming but offer higher objectivity and the
detection of balanced ischemia but have not yet been
applied to 3D datasets.
The DJS has several limitations, including the diffi-
culty of predicting the hemodynamic significance of
coronary disease from angiography alone, particularly for
intermediate lesions and the fact that it does not take into
account myocardial viability. For this reason, we excluded
any patients with a history of recent myocardial infarction
(3 months), but despite this 5 patients still had evi-
dence of small infarcts on CMR. Furthermore, the DJS
Figure 5
Correlation Between Ischemic Volume by
3D Whole Heart Myocardial Perfusion CMR
Versus Duke Jeopardy Score (n  48)
The dotted line indicates the 10% threshold cutoff previously quoted as being
the point above which revascularization may confer prognostic benefit. For this
graph only the 48 patients correctly identified by CMR were used.simply involves scoring the coronary tree segments and
does not directly measure the size of the myocardial
territory supplied by each vessel. This can cause problems
with true left and right coronary artery co-dominance,
unusual anatomic variations, and collaterization. How-
ever, although more precise scoring systems exist, they do
not have the same attributes of simplicity and universal
applicability.
Conclusions
3D whole heart myocardial perfusion CMR accurately
detects functionally significant coronary artery disease with
excellent sensitivity, specificity, and positive and negative
predictive values when compared with FFR. CMR esti-
mates of ischemic burden correlate closely with invasive DJS
index. Multicenter studies to determine the use of 3D
myocardial perfusion CMR as a noninvasive strategy for the
diagnosis and risk stratification of patients with suspected
Figure 6
Variability of Ischemic Volume Analysis by
3D Whole Heart Myocardial Perfusion CMR
by Bland-Altman Analysis
(A) Intraobserver and (B) interobserver variability of ischemic volume.CAD seem warranted.
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